Loading...
XLONSUN
Market cap6mUSD
Dec 23, Last price  
0.55GBP
1D
0.00%
1Q
-15.38%
Jan 2017
-87.06%
Name

Surgical Innovations Group PLC

Chart & Performance

D1W1MN
XLON:SUN chart
P/E
—
P/S
42.70
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
2.37%
Rev. gr., 5y
1.84%
Revenues
12m
+5.94%
3,032,0004,018,0004,460,0004,770,0004,312,0004,541,0007,045,0007,602,0007,639,0008,553,0004,029,0005,468,0006,089,0008,752,00010,969,00010,733,0006,329,0009,126,00011,340,00012,014,000
Net income
-509k
L
212,000402,000696,000765,000630,000525,0001,788,0001,738,000686,000800,000-9,457,000-2,033,000716,000626,000725,000-2,619,000-3,276,000-456,000264,000-509,000
CFO
400k
-17.70%
80,000230,000625,000-428,0007,0001,439,0002,202,0001,775,000612,0001,268,000-485,0001,506,0002,845,0001,608,0001,650,000594,0001,042,000-433,000486,000400,000
Earnings
Apr 16, 2025

Profile

Surgical Innovations Group plc, together with its subsidiaries, designs, develops, manufactures, and sells devices for use in minimally invasive surgery (SI) and precision engineering markets in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The company's SI Brand segment researches, develops, manufactures, and distributes SI branded minimally invasive devices. This segment also offers YelloPort Elite and YelloPort +plus laparoscopic port access systems; LogiRange resposable laparoscopic instrument systems; FastClamp laparoscopic clamping systems; and QuickRange single use laparoscopic instrumentation. Its OEM segment researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through own label or co-branding. This segment also provides design and development solutions for producing a final device; and researches, develops, manufactures, and sells minimally invasive technology products for precision engineering applications. The company's Distribution segment distributes medical products through Elemental Healthcare Ltd. It also designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. Surgical Innovations Group plc was incorporated in 1988 and is based in Leeds, the United Kingdom.
URL
https://www.sigroupplc.com/
IPO date
Jul 07, 1998
Employees
92
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
12,014
5.94%
11,340
24.26%
9,126
44.19%
Cost of revenue
12,572
11,000
9,096
Unusual Expense (Income)
NOPBT
(558)
340
30
NOPBT Margin
3.00%
0.33%
Operating Taxes
(219)
(321)
(129)
Tax Rate
NOPAT
(339)
661
159
Net income
(509)
-292.80%
264
-157.89%
(456)
-86.08%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
611
614
2,037
Long-term debt
1,859
2,501
1,657
Deferred revenue
Other long-term liabilities
165
165
165
Net debt
1,258
916
50
Cash flow
Cash from operating activities
400
486
(433)
CAPEX
(284)
(1,078)
(657)
Cash from investing activities
(688)
(1,078)
(657)
Cash from financing activities
(672)
(935)
(532)
FCF
1,154
(270)
(523)
Balance
Cash
1,212
2,199
3,644
Long term investments
Excess cash
611
1,632
3,188
Stockholders' equity
3,897
3,126
2,827
Invested Capital
11,700
11,485
10,559
ROIC
6.00%
1.47%
ROCE
2.59%
0.22%
EV
Common stock shares outstanding
932,816
935,946
936,564
Price
0.01
-62.50%
0.02
-31.91%
0.02
42.42%
Market cap
5,597
-62.63%
14,975
-31.96%
22,009
59.79%
EV
6,855
15,891
22,059
EBITDA
199
927
877
EV/EBITDA
34.45
17.14
25.15
Interest
132
98
130
Interest/NOPBT
28.82%
433.33%